GSTM1 and cancer: Methodological limitations of the clinical studies aimed at maintaining a high Hb level in cancer patients (Henke et al, 2003; Leyland-Jones et al, 2005), may have confounded the results and influenced the findings (Leyland-Jones and Mahmud, 2004; Vaupel and Mayer, 2004).